Pfizer Inc
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer International Commercial Division Revenues [legacy by Quarter
International Commercial Division Revenues [legacy 2024–2025 structure] ($M) ($M)
Pfizer International Commercial Division Revenues [legacy: $8,112M in Q4 2025, down 2.3% from a year earlier.
Where the Q4 2025 figure comes from
Calculated from reported figures: Q4 = full year (10-K) − nine months (10-Q)
Source: Form 10-K (filed 2026-02-26) ↗
Reported in Form 10-K Segment Note.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | International Commercial Division Revenues [legacy 2024–2025 structure] ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q4 2025 | Dec 31, 2025 | 8,112 | -2.3% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2025 | Sep 28, 2025 | 5,711 | +5.2% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2025 | Jun 29, 2025 | 5,512 | +6.8% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 30, 2025 | 5,156 | -0.4% | Form 10-Q (filed 2025-05-05) ↗ |
| Q4 2024 | Dec 31, 2024 | 8,299 | -11.5% | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2024 | Sep 29, 2024 | 5,428 | +4.1% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2024 | Jun 30, 2024 | 5,163 | -18.3% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 5,178 | -45.9% | Form 10-Q (filed 2025-05-05) ↗ |
| Q4 2023 | Dec 31, 2023 | 9,376 | – | Form 10-K (filed 2026-02-26) ↗ |
| Q3 2023 | Oct 1, 2023 | 5,214 | – | Form 10-Q (filed 2024-11-04) ↗ |
| Q2 2023 | Jul 2, 2023 | 6,323 | – | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2023 | Apr 2, 2023 | 9,575 | – | Form 10-Q (filed 2024-05-08) ↗ |
Cite this data
StockData. (2026). Pfizer International Commercial Division Revenues [legacy ($M), quarterly Q1 2023–Q4 2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/div-leg-intl-comm
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.